Inventor
Benjamin Jones
Inventor
Cardiff, CA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes27%
PatentTitleYear
10,407,4096-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD20199,944,6266-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD20189,708,296'6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD'20179,345,713'6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD'20169,187,497'Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP)'20159,181,255'Fused heteroaromatic pyrrolidinones as SYK inhibitors'20159,108,970'Fused heteroaromatic pyrrolidinones'20159,040,522'6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD'20158,822,470'Substituted pyrido[2,3-b]pyrazines'20148,450,323'Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4]oxazino[4,3-a]pyrazine'20138,440,689'Fused heteroaromatic pyrrolidinones'20138,338,595'Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis'20128,318,727'Polo-like kinase inhibitors'20128,138,168'Renin inhibitors'20128,124,606'Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3′,2′-e]pyrazin-6(6aH)-ones'20127,928,105'Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones'20117,928,227'2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders'20117,585,888'Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders'20097,563,791'Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis'20097,384,947'Fused tricyclic heterocycles useful for treating hyper-proliferative disorders'20087,351,735'Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders'20087,144,885'Fused tricyclic heterocycles useful for treating hyper-proliferative disorders'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2009Patents assigned to BAYER PHARMACEUTICALS CORP (4)· patent assignee history
2006–2011Based in Hamden, CT, US· patent location history
2008–2012Patents assigned to BAYER HEALTHCARE LLC (3)· patent assignee history
2009–2012Based in New Haven, CT, US· patent location history
2011–2016Patents assigned to TAKEDA PHARMACEUTICAL (11)· patent assignee history
2011–2019Based in Cardiff, CA, US· patent location history
2012–2015Patents assigned to JONES BENJAMIN (7)· patent assignee history
2012–2015Patents assigned to KIRYANOV ANDRE A (5)· patent assignee history
2013–2015Based in San Diego, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICAL | 11 | 2011–2016 |
| JONES BENJAMINself | 7 | 2012–2015 |
| KIRYANOV ANDRE A | 5 | 2012–2015 |
| BAYER PHARMACEUTICALS CORP | 4 | 2006–2009 |
| BAYER HEALTHCARE LLC | 3 | 2008–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cardiff, California, US | 13 | 2011–2019 |
| Hamden, CT, US | 5 | 2006–2011 |
| San Diego, California, US | 2 | 2013–2015 |
| New Haven, CT, US | 2 | 2009–2012 |